The world's first FDA-cleared dual-wave RF microneedling system, developed in South Korea for non-surgical skin rejuvenation.
SYLFIRM X is an energy-based medical device that delivers radiofrequency energy through gold-plated microneedles to stimulate collagen remodeling and treat pigmentary and vascular skin conditions — unlike dermal fillers, collagen stimulators, or fat-dissolving injections. It's used by dermatologists and aesthetic physicians worldwide and has received regulatory clearances in multiple countries, including FDA clearance for specific indications.
Designed primarily for vascular and pigment-related conditions — melasma, post-inflammatory hyperpigmentation, rosacea, diffuse redness, telangiectasia, vascular lesions, and active acne. PW mode selectively coagulates abnormal blood vessels while minimizing thermal injury to surrounding healthy tissue, which is one reason it's frequently chosen for melasma, a condition that can worsen with excessive heat from some other RF devices.
Designed primarily for collagen remodeling and skin tightening — skin laxity, fine lines, wrinkles, enlarged pores, acne scars, stretch marks, and general skin rejuvenation. CW mode delivers controlled thermal energy to stimulate fibroblasts, promoting collagen and elastin production.
Gold-plated, non-insulated microneedles deliver bipolar RF energy with adjustable penetration depth from 0.3 mm to 4.0 mm at 2 MHz. The non-insulated needles emit RF energy along their entire length for more uniform heating throughout the dermis, with 300-micron precision in depth control.
Typical protocols include 3–6 treatment sessions, spaced 4–6 weeks apart, with maintenance every 6–12 months depending on the indication and patient response. Measurable improvement often becomes evident after about three sessions, though some conditions, like pigmentation or pore size, may show earlier changes.
Because these risks exist with any injectable or energy-based treatment, procedures should only be performed by trained, licensed medical professionals with expertise in facial anatomy.
SYLFIRM X has received FDA clearance as a dual-wave RF microneedling system and is also marketed in Europe, Asia, Australia, and many other regions under applicable regulatory approvals. Approval status and permitted indications vary by country.
SYLFIRM X is considered one of the most advanced RF microneedling platforms currently available, particularly because its dual-wave technology addresses both vascular and pigmentary disorders through PW mode and collagen remodeling and skin tightening through CW mode. It has become especially recognized for treating melasma, rosacea, and post-inflammatory hyperpigmentation — conditions that can be challenging with conventional heat-based devices.
See the SYLFIRM X device page for the treatments it powers at SAS Clinic and to book a session.
